Vor Biopharma
VOR
VOR
58 hedge funds and large institutions have $400M invested in Vor Biopharma in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+10
Holders Change %
+20.83%
% of All Funds
0.94%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
15
Increased
26
Reduced
6
Closed
5
Calls
$217K
Puts
$42K
Net Calls
+$175K
Net Calls Change
+$164K
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$1.58M |
| 2 |
ABG
2
Ally Bridge Group
New York
|
$0 |
| 3 |
E
3
Ergoteles
New York
|
$152K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$172K |
| 5 |
5
Goldman Sachs
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Bank of America
Charlotte,
North Carolina
| $26.2K | +$14.9K | +2,243 | +132% |
|
52
Nisa Investment Advisors
St. Louis,
Missouri
| $26K | – | – | – |
|
53
Lazard Asset Management
New York
| $10K | +$10K | +1,614 | New |
|
54
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | -$5.26K | -734 | -47% |
|
55
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1.66K | – | – | – |
|
|
EBA
56
Eagle Bay Advisors
New York
| $998 | – | – | – |
|
57
Wells Fargo
San Francisco,
California
| $771 | +$40 | +6 | +5% |
|
58
Dimensional Fund Advisors
Austin,
Texas
| $276 | +$57 | +8,529 | +26% |
|
|
ABG
59
Ally Bridge Group
New York
| – | -$1.02M | -255,162 | Closed |
|
|
O
60
OrbiMed
New York
| – | -$445 | -111,808 | Closed |
|
|
61
Goldman Sachs
New York
| – | -$76K | -19,062 | Closed |
|
|
CUAMC
62
China Universal Asset Management Company
Shanghai,
China
| – | -$1K | -356 | Closed |
|